Evidence map›Paper›PMID 37568222›Full record

ArticleJournal of medical case reports2023

Left ventricle endomyocardial fibrosis: a case report.

Raquel Reis Soares, Maria Clara Martins Avelar, Sofia Lucena Zanetti, Joao Victor Tavares Mendonça Garreto, Vinicius Dinelli Guimaraes, Elisa Soares Ferber, Mayumi de Oliveira Drumond, Matheus Ferber, Leonardo Ferber

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Raquel Reis SoaresBiocor Rede D'Or Institute, Nova Lima, Brazil. raquelr.soares@hotmail.com.ORCID http://orcid.org/0000-0003-2104-0186
Maria Clara Martins AvelarFaculdade Ciências Médicas de Minas Gerais, Belo Horizonte, Brazil.
Sofia Lucena ZanettiFaculdade Ciências Médicas de Minas Gerais, Belo Horizonte, Brazil.
Joao Victor Tavares Mendonça GarretoBiocor Rede D'Or Institute, Nova Lima, Brazil.
Vinicius Dinelli GuimaraesBiocor Rede D'Or Institute, Nova Lima, Brazil.
Elisa Soares FerberUniversidade José do Rosário Vellano - UNIFENAS, Alfenas, Brazil.
Mayumi de Oliveira DrumondUniversidade Federal dos Vales do Jequitinhonha e Mucuri, Teófilo Otoni, Brazil.
Matheus FerberBiocor Rede D'Or Institute, Nova Lima, Brazil.
Leonardo FerberBiocor Rede D'Or Institute, Nova Lima, Brazil.
Biocor Institute · BRFaculdade de Ciências Médicas de Minas Gerais · BRHospital das Clínicas da Universidade Federal de Minas Gerais · BRUniversidade Federal dos Vales do Jequitinhonha e Mucuri · BRUniversidade José do Rosário Vellano · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEndomyocardial fibrosis is a grim disease. It is the most common restrictive cardiomyopathy worldwide, but the exact etiology and pathogenesis both remain unknown. Endomyocardial fibrosis is recurrently associated with chronic eosinophilia and probable dietary, environmental, and infectious factors, which contribute not only to the onset of the disease (an inflammatory process) but also to its progression and maintenance (endomyocardial damage and scar formation). The trademark of the disease is the fibrotic obliteration of the affected ventricle. The combination of such processes produces focal or diffuse endocardial thickening and fibrosis, which leads to restrictive physiology. Endomyocardial fibrosis affects the apices of the right and the left ventricle in around 50% of cases and most often extends to the posterior leaflet of the mitral valve. Sometimes it involves the papillary muscle and chordae tendineae, causing atrioventricular valve dysfunction. The fibrosis does not affect extracardiac organs. This cardiomyopathy is most recurrent in tropical areas of the world. CASE PRESENTATION: A 67-year-old Black male with past medical history of schistosomiasis infection in childhood presented with progressive dyspnea, lower extremity edema, and weakness for 2 years. He was diagnosed with endomyocardial fibrosis. The echocardiogram showed an increased thickness in the septum (17 mm) and free left ventricular wall (15 mm), obliteration of the left ventricular apex and inflow tract, and mitral valve regurgitation. Cardiac magnetic resonance imaging revealed apical left ventricle wall thickening with left ventricular apical obliteration associated with enlargement of the respective atrium. Delayed enhancement imaging showed endomyocardium enhancement involving left ventricular apex, mitral valve regurgitation due to annulus dilation, and a thrombus at left ventricular apex. He underwent open heart surgery with mitral valve replacement, endocardial decortication, endomyocardiectomy, and two-vessel coronary artery bypass grafting as preoperative coronary angiogram showed mild right coronary artery and proximal left anterior descending artery severe lesions. Postoperative course was uncomplicated, and he was discharged successfully from the hospital. Six months after surgery, he was New York Heart Association functional class I.

conclusionThe purpose of this case report is to illustrate the aspects of endomyocardial fibrosis by reporting a case of this entity. In conclusion, progress in imaging techniques and treatment in a reference institution for cardiac diseases contribute to earlier diagnosis and survival in patients with endomyocardial fibrosis.

Indexed as

Endomyocardial FibrosisMitral Valve InsufficiencyAgedFibrosisHeart VentriclesHumansMaleMyocardiumCardiac magnetic resonanceCardiac surgeryEndomyocardial fibrosisHeart failureHypereosinophiliaRestrictive cardiomyopathy

Identifiers

PMID37568222
PMCPMC10422788
OpenAlexW4385755693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.